TABLE 2.
Virological and immunological parameters at treatment interruption and follow-up
| Parameter | Value |
|---|---|
| No. of patients with HIV RNA load of <1.7 log10 | |
| copies/ml at wk 24/total no. of patients (%) | 21/24 (87.5) |
| No. of patients who stopped HAART at wk 24/total | |
| no. of patients | 21/24 |
| Median (range) peak HIV RNA load (log10copies/ml) | 4.26 (3-5) |
| Median (range) time to peak HIV RNA load (wk) | 4 (2-6) |
| No. of patients who resumed therapy/total no. of patients | 13/21 |
| Median (range) delay in resuming therapy (wk) | 60 (9.2-68.4) |
| Median (range) CD4 cell count at time of restarting | |
| therapy (cells/mm3) | 551 (156-778) |
| Median (range) HIV RNA load at time of resuming | |
| therapy (log10copies/ml) | 4.8 (2.9-5.7) |
| Median (range) time to achieve undetectable pVL after | |
| resuming HAART (wk) | 8 (4-16) |
| Median (range) CD4 cell count at W96 in patients not | |
| resuming treatment (cells/mm3) | 412 (299-832) |
| Median (range) HIV RNA load at W96 in patients not | |
| resuming treatment (log10 copies/ml) | 4 (1.7-4.6) |